SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-318557
Filing Date
2017-10-25
Accepted
2017-10-25 09:02:04
Documents
8
Period of Report
2017-10-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d469259d8k.htm 8-K 24967
2 EX-3.1 d469259dex31.htm EX-3.1 77846
3 EX-10.1 d469259dex101.htm EX-10.1 605986
4 EX-10.2 d469259dex102.htm EX-10.2 170172
5 EX-10.3 d469259dex103.htm EX-10.3 82232
6 EX-99.1 d469259dex991.htm EX-99.1 7968
7 GRAPHIC g469259dsp023.jpg GRAPHIC 451980
8 GRAPHIC g469259dsp024.jpg GRAPHIC 215502
  Complete submission text file 0001193125-17-318557.txt   1889957
Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Filer) CIK: 0001316175 (see all company filings)

IRS No.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34637 | Film No.: 171152154
SIC: 2834 Pharmaceutical Preparations